To confirm the regulatory relationship between YAP1 and LINC00152 in CRC, we first demonstrated that YAP1 overexpression or inhibition resulted in significant change of LINC00152 expression levels (Figure S2, Supporting Information). Here, YAP1 is linked to colorectal carcinoma.